Effects of Chronic Insomnia on the Neuroendocrine Regulation of Glucose and Lipid Metabolism

NCT00442624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2012-03-09

No results posted yet for this study

Summary

We aim to assess the influence of chronic insomnia on the neuroendocrine regulation of the glucose and lipid metabolism to more clearly define the metabolic derangements associated with chronic insomnia and to prove that chronic insomnia is associated with increased levels of stress hormones, cytokines and impaired insulin sensitivity.

Conditions

  • Chronic Insomnia

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Stefan Bilz, MD · Cantonal Hospital of St. Gallen

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Completion
2008-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00442624 on ClinicalTrials.gov